Pablo
Aguiar Fernández
Publicacións (139) Publicacións de Pablo Aguiar Fernández
2024
-
Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models
International Journal of Pharmaceutics, Vol. 652
-
Partial volume correction in longitudinal tau PET studies: is it really needed?
NeuroImage, Vol. 289
-
Perspectives of the European Association of Nuclear Medicine on the role of artificial intelligence (AI) in molecular brain imaging
European Journal of Nuclear Medicine and Molecular Imaging
2023
-
A murine model of BSCL2-associated Celia's encephalopathy
Neurobiology of Disease, Vol. 187
-
Association of periodontitis with cognitive decline and its progression: Contribution of blood-based biomarkers of Alzheimer's disease to this relationship
Journal of Clinical Periodontology, Vol. 50, Núm. 11, pp. 1444-1454
-
EANM position paper: theranostics in brain tumours—the present and the future
European Journal of Nuclear Medicine and Molecular Imaging
-
FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective
European Journal of Nuclear Medicine and Molecular Imaging
-
Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity
JAMA neurology
-
Pharmacokinetic Evaluation of New Drugs Using a Multi-Labelling Approach and PET Imaging: Application to a Drug Candidate with Potential Application in Neuromuscular Disorders
Biomedicines, Vol. 11, Núm. 2
-
Prevalencia de dislipemia aterogénica, factores relacionados y grado de control lipídico en la población general de Galicia: Estudio GALIPEMIAS
Clínica e investigación en arteriosclerosis, Vol. 35, Núm. 4, pp. 178-184
-
Quantitative PET tracking of intra-articularly administered 89Zr-peptide-decorated nanoemulsions
Journal of Controlled Release, Vol. 356, pp. 702-713
2022
-
18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 49, Núm. 4, pp. 1242-1253
-
Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence
Pharmaceutics, Vol. 14, Núm. 10
-
Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [18F]MC225 and PET
Journal of Controlled Release, Vol. 347, pp. 500-507
-
Impact of spill-in counts from off-target regions on [18F]Flortaucipir PET quantification
NeuroImage, Vol. 259
-
PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model
International Journal of Pharmaceutics, Vol. 627
2021
-
A systematic review of pet textural analysis and radiomics in cancer
Diagnostics, Vol. 11, Núm. 2
-
Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model
Pharmaceutics, Vol. 13, Núm. 10
-
Biodistribution of 68/67Ga-radiolabeled sphingolipid nanoemulsions by pet and spect imaging
International Journal of Nanomedicine, Vol. 16, pp. 5923-5935
-
Computational Issues in the Application of Functional Data Analysis to Imaging Data
Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)